Accelerate Your Drug Discovery Workflow
Producing antibodies through hybridomas leads to sensitive and specific antibodies, but there are several drawbacks associated with this method, including long lead times and significant cost. Phage display is a valid alternative approach that is faster and less labor intensive and avoids animal welfare concerns.
Read this article to learn:
- An overview of the challenges and limitations posed by in vivo antibody production methods
- Why phage display is a valid alternative to hybridoma and animal model approaches
- How the Pioneer Antibody Discovery Platform can help advance your antibody development
Download the Article
Share a little information with us to access the entire article now.
Thank you for your interest!
Your download is ready.Download PDF
Content you'll also find interesting
What to Consider When Choosing a Library for Drug Discovery
Learn the key differences between library formats (immune, naïve, synthetic, and semi-synthetic) and find out the best source for your next discovery project.
Overcoming Challenges in Biotherapeutic Antibody Development
What to do when your antibody development project fails? We look at how to overcome challenges in therapeutic antibody discovery. Let us help you succeed.